Eli Lilly Director J. Erik Fyrwald Acquires Retainer Shares via Deferral Plan
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing Alert: ELI LILLY & Co ($LLY) Insider: Fyrwald J Erik (Director) Type: Acquisition (Award / Deferred Retainer) Shares Transacted: 7.9951 @ $1,240.34 (~$9,916.64) Post-Transaction Holdings: 75,544.1259 shares Significance: Low
Comprehensive Analysis
Executive Summary
On October 20, 2026, Eli Lilly & Co ($LLY) filed a Form 4 reporting an acquisition of common stock by Director J. Erik Fyrwald. On October 19, 2026, Fyrwald acquired 7.9951 shares of common stock at a price of $1,240.34 per share, totaling approximately $9,916.64.
Transaction Details
- Security: Common Stock
- Transaction Code: A (Award/Grant)
- Shares Acquired: 7.9951 shares
- Execution Price: $1,240.34
- Total Transaction Value: $9,916.64
- Ownership Post-Transaction: 75,544.1259 direct shares
- Nature of Transaction: Pursuant to the Lilly Directors' Deferral Plan, the reporting person elected to receive stock units in lieu of cash compensation, which will be settled in common stock upon separation from service.
Market & Significance Analysis
This transaction carries Low trading significance. It represents a routine deferral of director retainer fees into equity under a structured company compensation plan rather than an open-market purchase or discretionary trading activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.